logo-loader
viewCollagen Solutions PLC

Director/PDMR Shareholding

/**/ ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .aj{size:595.3pt 841.9pt;margin:72.3pt 2.0cm 42.55pt 2.0cm;}div.aj{}p.cs{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; line-height: normal; margin-bottom: 0cm; text-align: justify}p.ct{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: center}span.co{color:windowtext}p.cu{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm}p.cv{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; text-align:justify;line-height:normal}span.cm{color:black}p.cw{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}span.ck{color:#00000A} table.cx{width:469.95pt;margin-left:-10.8pt;border-collapse:collapse}tr.ca{height:2.0cm}td.ch{width:118.3pt;padding:0cm 5.4pt 0cm 5.4pt; height:2.0cm}p.cy{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: -74.25pt; margin-top: 0cm; text-align: justify; text-decoration: underline}td.cf{width:162.5pt;padding:0cm 5.4pt 0cm 5.4pt; height:2.0cm}p.cz{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify; text-decoration: underline}td.cb{width:156.75pt;padding:0cm 5.4pt 0cm 5.4pt; height:2.0cm}p.da{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; text-decoration: underline}p.db{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: -114.85pt; margin-top: 0cm; text-decoration: underline}p.dc{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-div: italic; font-weight: bold; line-height: normal; margin-bottom: 0cm; margin-left: 0cm; margin-right: -114.85pt; margin-top: 0cm; text-align: justify} td.by{width:118.3pt;padding:0cm 5.4pt 0cm 5.4pt}p.dd{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal;background:white}td.bx{width:162.5pt;padding:0cm 5.4pt 0cm 5.4pt}td.bw{width:156.75pt;padding:0cm 5.4pt 0cm 5.4pt}p.de{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif"; font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}table.df{margin-left:-5.4pt;border-collapse:collapse;border:none}td.bq{width:9.6pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dg{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold}span.bt{font-size:11.0pt;font-family:"Calibri","sans-serif"}p.dh{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal} td.bp{width:407.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.bo{width:9.6pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}p.ai,li.ai,div.ai{margin:0cm;margin-bottom:.0001pt;text-autospace:none;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;}td.bn{width:143.25pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.bl{width:253.35pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.di{margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:36.0pt;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom: .0001pt;text-indent:-18.0pt;line-height:normal}p.dj{margin-top:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:36.0pt;margin-bottom:.0001pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom: .0001pt;text-indent:-18.0pt;line-height:normal}p.dk{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:36.0pt;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom: .0001pt;text-indent:-18.0pt;line-height:normal}td.bk{width:407.4pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dl{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm} table.dm{border-collapse:collapse;border:none}tr.bg{height:27.25pt}td.bi{width:110.4pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}p.dn{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}td.bh{width:110.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}td.bf{width:110.4pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}td.be{width:110.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:27.25pt}span.bc{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:windowtext}span.az{font-size:11.0pt;line-height:107%;font-family:"Calibri","sans-serif"}br.ba{page-break-before:always} p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}table.do{width:487.15pt;margin-left:-8.25pt;border-collapse:collapse}tr.au{height:12.35pt}td.ax{width:248.55pt; padding:0cm 5.4pt 0cm 5.4pt;height:12.35pt}p.dp{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify}td.av{width:217.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:12.35pt}p.dq{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;line-height: normal; margin-bottom: 0cm; text-align: right}td.at{width:275.55pt; padding:0cm 5.4pt 0cm 5.4pt}td.as{width:190.0pt;padding:0cm 5.4pt 0cm 5.4pt}td.ar{width:248.55pt; padding:0cm 5.4pt 0cm 5.4pt} td.aq{width:217.0pt; padding:0cm 5.4pt 0cm 5.4pt}span.ap{color:#00000A;text-decoration:none}td.ao{width:230.55pt;padding:0cm 5.4pt 0cm 5.4pt}td.an{width:235.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.dr{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}td.am{border:none}span.ak{font-family:"Calibri","sans-serif"; font-weight:normal}p.ds{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify} /**/
RNS Number : 1513F
Collagen Solutions PLC
11 July 2019
 

 

 

Collagen Solutions Plc

(the "Company")

 

Director/PDMR Dealing

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that 2,500,000 options ("Options") over the ordinary shares of 1p each in the share capital of the Company ("Ordinary Shares") were granted to Directors and Persons Discharging Managerial Responsibilities on 10 July 2019.

 

The Options, which will vest in three equal tranches over three years, have an exercise period of ten years from grant and have an exercise price per Option of 3.85p. The Options vest in full upon the closing middle market price per Ordinary Share achieving 10p and positive cash flows from operations being sustained for any period of six months following date of grant.  

 

 

Director/PDMR

Position

Number of

Ordinary

Shares options granted

 

 

Lou Ruggiero

Chief Business Officer

1,000,000

Kevin Darling 

PDMR / VP Tissue Products

   750,000

Chris Wattengel

PDMR / VP Global R&D

   750,000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1.    Lou Ruggiero

2.    Kevin Darling

3.    Christian Wattengel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1.    Chief Business Officer

2.    PDMR / VP Tissue Products

3.    PDMR / VP Global R&D

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Collagen Solutions plc

b)

 

LEI

 

 

213800IFY1CVGRGETL95

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each  

 

 

ISIN Code: GB00B94T6Y14

 

 

 

 

b)

 

Nature of the transaction

 

 

Grant of options over ordinary shares of 1p each exercisable at 3.85p

c)

 

Price(s) and volume(s)

 

 

 

Price (s)

 

Volume(s)

1. 0p per share

 

1,000,000

2. 0p per share


   750,000

3. 0p per share

    750,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

2,500,000

 

 

N/a

 

 

e)

 

Date of the transaction

 

 

10 July 2019

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

 

 

 

Enquiries: 

 

Collagen Solutions Plc

Contact via Walbrook

Jamal Rushdy, Chief Executive Officer   

 

Hilary Spence, Chief Financial Officer

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

 

Giles Balleny

Tel: 0207 397 8900

Stephen Keys

 

 

 

Walbrook PR

    Tel: 020 7933 8780 or [email protected]

Anna Dunphy

Mob: 07876 741 001

       

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHCKKDBABKDAOD

Quick facts: Collagen Solutions PLC

Price: 3.45

Market: LSE
Market Cap: £15.31 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Collagen Solutions released financial number showing more...

Collagen Solutions (LON: COS) CEO Jamal Rushdy joined Steve Darling from Proactive to discuss the company releasing their financial numbers that show impressive double-digit sales growth.  Rushdy talks about the numbers and also their tissue division that continues to be a revenue driver.

4 weeks, 2 days ago